|
Volumn 28, Issue 6, 2008, Pages 707-709
|
Atypical antipsychotics and metabolic outcomes in ChinesePatients: A comparison of olanzapine and risperidone
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CHOLESTEROL;
GLUCOSE;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
OLANZAPINE;
RISPERIDONE;
TRIACYLGLYCEROL;
BENZODIAZEPINE DERIVATIVE;
NEUROLEPTIC AGENT;
ADULT;
BLOOD PRESSURE;
BODY HEIGHT;
BODY WEIGHT;
CHINESE;
DEMOGRAPHY;
DRINKING BEHAVIOR;
DRUG EFFECT;
DRUG MONITORING;
DYSLIPIDEMIA;
FAMILY HISTORY;
FEMALE;
GLUCOSE BLOOD LEVEL;
HEART RATE;
HONG KONG;
HUMAN;
INCIDENCE;
LETTER;
LIPID BLOOD LEVEL;
MAJOR CLINICAL STUDY;
MALE;
METABOLIC SYNDROME X;
PRIORITY JOURNAL;
RISK FACTOR;
SCHIZOPHRENIA;
SEX DIFFERENCE;
SIDE EFFECT;
SMOKING;
TREATMENT OUTCOME;
WEIGHT GAIN;
AGED;
CHEMICALLY INDUCED DISORDER;
CHINA;
COMPARATIVE STUDY;
CROSS-SECTIONAL STUDY;
DOSE RESPONSE;
METABOLISM;
PILOT STUDY;
ADULT;
AGED;
ANTIPSYCHOTIC AGENTS;
BENZODIAZEPINES;
CHINA;
CROSS-SECTIONAL STUDIES;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DYSLIPIDEMIAS;
FEMALE;
HUMANS;
MALE;
METABOLIC SYNDROME X;
PILOT PROJECTS;
RISK FACTORS;
RISPERIDONE;
SCHIZOPHRENIA;
SEX FACTORS;
YOUNG ADULT;
|
EID: 59049107405
PISSN: 02710749
EISSN: None
Source Type: Journal
DOI: 10.1097/JCP.0b013e31818ce71f Document Type: Letter |
Times cited : (6)
|
References (8)
|